After years of clinical suspicion, large studies confirm elevated risk across multiple cancers From Lewis S Blevins Jr., MD – Professor of Neurological Surgery, Medical Director of the California Center for Pituitary Disorders at UCSF
Dr. Blevins Corner
Medical comments from Dr. Lewis Blevins MD. Director Center for Pituitary Disorders at University California San Francisco
Non-functioning pituitary adenomas
August 8, 2017
Dr. Lewis Blevins reviews non-functioning pituitary adenomas. These tumors, which typically do not secrete hormones, can pose major challenges due to their ability to grow large and cause mass effects such a vision issues and headaches,
Pseudo-acromegaly: a few comments
February 27, 2017
From the desk of Lewis S Blevins Jr. MD – cofounder. I’m not sure this term really exists. It does, however, seem to be rather fitting at times. I encounter patients who look acromegalic but
Comments on a recent AACE article on the diagnosis of recurring Cushing’s Disease.
February 18, 2017
From the desk of Dr. Lewis Blevins – cofounder – This article –Diagnosis of recurrence in Cushing’s disease: American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review – summarizes recent
The withdrawal of dopamine agonist therapies in prolactinomas
January 22, 2017
PODCAST: Today’s podcast focuses on Dr. Blevins’ thoughts on a recent paper published in The Pituitary Journal. You can review a summary of the article here. Dr. Blevins reviews some of the relevant topics and makes critical
Prolactinomas and tumor regression with dopamine agonist drugs.
January 17, 2017
From Lewis S Blevins Jr. MD – Macroadenomas and massive macroadenomas tend to regress significantly in response to treatment with dopamine agonist drugs. I would say that about 30% of tumors do not regress at
The work of a pituitary endocrinologist
January 5, 2017
In today’s podcasts, we are talking to Dr. Lewis Blevins about the work of a pituitary endocrinologist. We delve into the details of the work he does in clinic as a highly specialized neuro or
Pituitary surgery: what are the factors that determine it.
December 18, 2016
Podcast: In this podcast we discuss the indications for pituitary surgery. What are the factors that make the procedure necessary? We ask Dr. Blevins how he decides to recommend it. When does he treat a
Discussing the rationale for Pegvisomant dose adjustments
December 7, 2016
Listen to this engaging podcast where PWN cofounders Dr. Blevins and JD Faccinetti discuss the ins and outs of a Somavert (pegvisomant for injection) dose adjustment based on a recent case. . Don’t miss it!
Taking testosterone replacement for hypogonadism due to pituitary disease? Read this.
November 21, 2016
From Lewis S Blevins, Jr. MD – I see a lot of men who are concerned about taking testosterone replacement for hypogonadism due to pituitary disease. Their concerns are primarily related to whether exogenous testosterone
Hyponatremia after Pituitary Surgery.
July 21, 2016
From Lewis S Blevins Jr. MD: A 37-year-old woman presented with visual compromise and headache. MRI demonstrated a 2.0 cm cystic pituitary lesion thought to be representative of a Rathke’s cleft cyst. Pituitary functions were
“The Art of Neuroendocrinology”
May 6, 2016
A case-based approach to medical decision making. Edited by Lewis S Blevins Jr., MD “The Art of Neuroendocrinology: A case-based approach to medical decision-making” is not your standard textbook of pituitary endocrinology. This comprehensive
Hyponatremia: Advances in management
April 23, 2016
A lecture delivered at Internal Medicine Grand Rounds by Dr. Lewis Blevins at the University of California, Fresno March 2016.